Cargando…
Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection
Solitary large hepatocellular carcinoma (SLHCC) is a specific subtype of HCC with unique characteristics. It is of great interest to assess and stratify the prognosis of SLHCCs after curative resection. In this study, we tried to construct a prognostic nomogram for SLHCC following curative resection...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703492/ https://www.ncbi.nlm.nih.gov/pubmed/33312945 http://dx.doi.org/10.3389/fonc.2020.556489 |
_version_ | 1783616650122100736 |
---|---|
author | Zhuang, Hongkai Zhou, Zixuan Ma, Zuyi Huang, Shanzhou Gong, Yuanfeng Zhang, Zedan Hou, Baohua Yu, Weixuan Zhang, Chuanzhao |
author_facet | Zhuang, Hongkai Zhou, Zixuan Ma, Zuyi Huang, Shanzhou Gong, Yuanfeng Zhang, Zedan Hou, Baohua Yu, Weixuan Zhang, Chuanzhao |
author_sort | Zhuang, Hongkai |
collection | PubMed |
description | Solitary large hepatocellular carcinoma (SLHCC) is a specific subtype of HCC with unique characteristics. It is of great interest to assess and stratify the prognosis of SLHCCs after curative resection. In this study, we tried to construct a prognostic nomogram for SLHCC following curative resection through a retrospective analysis of 202 SLHCC cases. Seven prognostic factors were identified and integrated to establish a novel prognostic nomogram, which included tumor size, microvascular invasion, tumor differentiation, Ki67 (%), α-fetoprotein (AFP), carbohydrate antigen 125 (CA125), and HBsAg status. The Harrell's concordance index (C-index) of the nomogram for overall survival (OS) in the training, validation, and whole sets was 0.752, 0.703, and 0.733, respectively. Furthermore, the area under the curve (AUC) of the receiver operating characteristic (ROC) curve of the nomogram for predicting 1-, 3-, and 5-year OS indicated that the nomogram had an optimal discrimination of the prognostic prediction for SLHCC. The total score of each patient was calculated based on the nomogram, and patients were divided into three subgroups: low-risk group (total score ≦ 107), medium-risk group (107 < total score ≤ 125), and high-risk group (total score > 125). The 1-, 3-, and 5-year OS rates of the low-risk, medium-risk, and high-risk groups in the whole set were 89.3 vs. 70.1 vs. 33.3%, 76.6 vs. 37.8 vs. 14.5%, and 69.8 vs. 25.1 vs. 12.5%, respectively (P < 0.001). Similar results were shown in terms of the recurrence-free survival (RFS) rate. By analyzing 101 cases of recurrent tumors, transarterial chemoembolization (TACE) plus radiofrequency ablation (RFA)/surgery was found to prolong patient survival when compared to TACE alone in the low-risk group, but not in the medium/high-risk group. In conclusion, our prognostic nomogram successfully stratifies the prognosis for SLHCC after curative resection, which deserves further study in future clinical practice. |
format | Online Article Text |
id | pubmed-7703492 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77034922020-12-10 Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection Zhuang, Hongkai Zhou, Zixuan Ma, Zuyi Huang, Shanzhou Gong, Yuanfeng Zhang, Zedan Hou, Baohua Yu, Weixuan Zhang, Chuanzhao Front Oncol Oncology Solitary large hepatocellular carcinoma (SLHCC) is a specific subtype of HCC with unique characteristics. It is of great interest to assess and stratify the prognosis of SLHCCs after curative resection. In this study, we tried to construct a prognostic nomogram for SLHCC following curative resection through a retrospective analysis of 202 SLHCC cases. Seven prognostic factors were identified and integrated to establish a novel prognostic nomogram, which included tumor size, microvascular invasion, tumor differentiation, Ki67 (%), α-fetoprotein (AFP), carbohydrate antigen 125 (CA125), and HBsAg status. The Harrell's concordance index (C-index) of the nomogram for overall survival (OS) in the training, validation, and whole sets was 0.752, 0.703, and 0.733, respectively. Furthermore, the area under the curve (AUC) of the receiver operating characteristic (ROC) curve of the nomogram for predicting 1-, 3-, and 5-year OS indicated that the nomogram had an optimal discrimination of the prognostic prediction for SLHCC. The total score of each patient was calculated based on the nomogram, and patients were divided into three subgroups: low-risk group (total score ≦ 107), medium-risk group (107 < total score ≤ 125), and high-risk group (total score > 125). The 1-, 3-, and 5-year OS rates of the low-risk, medium-risk, and high-risk groups in the whole set were 89.3 vs. 70.1 vs. 33.3%, 76.6 vs. 37.8 vs. 14.5%, and 69.8 vs. 25.1 vs. 12.5%, respectively (P < 0.001). Similar results were shown in terms of the recurrence-free survival (RFS) rate. By analyzing 101 cases of recurrent tumors, transarterial chemoembolization (TACE) plus radiofrequency ablation (RFA)/surgery was found to prolong patient survival when compared to TACE alone in the low-risk group, but not in the medium/high-risk group. In conclusion, our prognostic nomogram successfully stratifies the prognosis for SLHCC after curative resection, which deserves further study in future clinical practice. Frontiers Media S.A. 2020-11-16 /pmc/articles/PMC7703492/ /pubmed/33312945 http://dx.doi.org/10.3389/fonc.2020.556489 Text en Copyright © 2020 Zhuang, Zhou, Ma, Huang, Gong, Zhang, Hou, Yu and Zhang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Zhuang, Hongkai Zhou, Zixuan Ma, Zuyi Huang, Shanzhou Gong, Yuanfeng Zhang, Zedan Hou, Baohua Yu, Weixuan Zhang, Chuanzhao Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection |
title | Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection |
title_full | Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection |
title_fullStr | Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection |
title_full_unstemmed | Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection |
title_short | Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection |
title_sort | prognostic stratification based on a novel nomogram for solitary large hepatocellular carcinoma after curative resection |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703492/ https://www.ncbi.nlm.nih.gov/pubmed/33312945 http://dx.doi.org/10.3389/fonc.2020.556489 |
work_keys_str_mv | AT zhuanghongkai prognosticstratificationbasedonanovelnomogramforsolitarylargehepatocellularcarcinomaaftercurativeresection AT zhouzixuan prognosticstratificationbasedonanovelnomogramforsolitarylargehepatocellularcarcinomaaftercurativeresection AT mazuyi prognosticstratificationbasedonanovelnomogramforsolitarylargehepatocellularcarcinomaaftercurativeresection AT huangshanzhou prognosticstratificationbasedonanovelnomogramforsolitarylargehepatocellularcarcinomaaftercurativeresection AT gongyuanfeng prognosticstratificationbasedonanovelnomogramforsolitarylargehepatocellularcarcinomaaftercurativeresection AT zhangzedan prognosticstratificationbasedonanovelnomogramforsolitarylargehepatocellularcarcinomaaftercurativeresection AT houbaohua prognosticstratificationbasedonanovelnomogramforsolitarylargehepatocellularcarcinomaaftercurativeresection AT yuweixuan prognosticstratificationbasedonanovelnomogramforsolitarylargehepatocellularcarcinomaaftercurativeresection AT zhangchuanzhao prognosticstratificationbasedonanovelnomogramforsolitarylargehepatocellularcarcinomaaftercurativeresection |